Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)

Samlyn Capital LLC bought a new position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The insti… [+3796 chars]

Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)

Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)

Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)

Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)
Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR)
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Breakthrough: Will DCGI-approved Entod Pharma's PresVu eyedrops eliminate need for reading glasses?
Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
The Peanut Allergy Vaccine